Current Medicinal Chemistry

This journal supports open access

Editor-in-Chief:

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK

Back

Become EABM
Become Reviewer



Editorial: VDAC As a Pharmaceutical Target free to download

Volume:24   Issue:40
Pp: 4417-4418
Angela Messina
DOI: 10.2174/092986732440180104091815



VDAC-Targeted Drugs Affecting Cytoprotection and Mitochondrial Physiology in Cerebrovascular and Cardiovascular Diseases

Volume:24   Issue:40
Pp: 4419-4434
Andonis Karachitos, Joaquin Jordan and Hanna Kmita*
DOI: 10.2174/0929867324666170530073238



VDAC1 as a Player in Mitochondria-Mediated Apoptosis and Target for Modulating Apoptosis

Volume:24   Issue:40
Pp: 4435-4446
Varda Shoshan-Barmatz*, Yakov Krelin and Quan Chen
DOI: 10.2174/0929867324666170616105200



Anti-Cancer Compounds Targeted to VDAC: Potential and Perspectives

Volume:24   Issue:40
Pp: 4447-4469
Simona Reina* and Vito De Pinto *
DOI: 10.2174/0929867324666170530074039



Recent Advances in Cancer Drug Development: Targeting Induced Myeloid Cell Leukemia-1 (Mcl-1) Differentiation Protein

Volume:24   Issue:40
Pp: 4488-4514
Mohammad Abid*, Yogesh A. Sonawane, Jacob I. Contreras, Sandeep Rana and Amarnath Natarajan*
DOI: 10.2174/0929867324666170912092659



Chemistry in the Bioactivity of Chlorophylls: An Overview

Volume:24   Issue:40
Pp: 4515-4536
Antonio Perez-Galvez , Isabel Viera and Maria Roca *
DOI: 10.2174/0929867324666170714102619